US FDA says Novo’s obesity pill TV ad is false or misleading
The US Food and Drug Administration said a television advertisement for Novo Nordisk’s weight-loss pill is “false or misleading,” according to a letter dated February 5. Wegovy pens are sorted at a packaging line at Novo Nordisk’s facility in Hillerod, Denmark, March 8, 2024. (File Photo/REUTERS) The health regulator said the television spot misleadingly suggests … Read more